Factors preventing African Americans from seeking early intervention in the treatment of ischemic strokes

Journal of the National Medical Association

Volumn 93, Issue 2, 2001, Pages 43-46

  King, Dwight F ^a,b   Trouth, Annapurni Jayam ^a   Adams, Alice O ^a  

^a HOWARD UNIVERSITY HOSPITAL   (United States)

^b NONE   (United States)

Author keywords

African Americans; Recombinant tissue plasminogen activator; Stroke

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ACUTE DISEASE; ADULT; AFRICAN AMERICAN; AGE; AGED; ARTICLE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; DENIAL; EDUCATION; EMERGENCY HEALTH SERVICE; ETHNOLOGY; FEMALE; FOLLOW UP; HEALTH SURVEY; HUMAN; INTENSIVE CARE; MALE; MIDDLE AGED; PATIENT ATTITUDE; PROSPECTIVE STUDY; RISK ASSESSMENT; SEX DIFFERENCE; STATISTICS; UNITED STATES; UTILIZATION REVIEW;

ACUTE DISEASE; ADULT; AFRICAN AMERICANS; AGE FACTORS; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CRITICAL CARE; DENIAL (PSYCHOLOGY); EMERGENCY SERVICE, HOSPITAL; FEMALE; FOLLOW-UP STUDIES; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEX FACTORS; TISSUE PLASMINOGEN ACTIVATOR; UNITED STATES;

EID: 0035532638     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Raichle ME. The pathophysiology of brain ischemia. Ann Neurol. 1983;13:2-10.
2. Feinleib M, Ingster L, Rosenberg H, Maurer J, Singh G, Kochanek K. Time trend, cohort effects, and geographic patterns in stroke mortality: United States. Ann Epidemiol. 1993;3:458-465.
3. Centers for Disease Control and Prevention. Decline in death from heart disease and stroke United States 1990-1999. MMWR. 1999;48:649-656.
4. Foulkes MA, Wolf PA, Price TR, Mohr JP, Hier DB. The enigma of the decline in stroke deaths in the United States: design methods and baseline characteristics. Stroke. 1988;19:547-554.
5. Gillum RF. Stroke mortality in blacks: disturbing trends. Stroke. 1999;30:1711-1715.
6. Wolf P, Kannel W. Reduction of stroke through risk factor modification. Semin Neurol. 1986;6:243-253.
7. American Heart Association. Heart and Stroke Facts: Statistical Supplement. Dallas, TX: American Heart Association; 1996.
8. American Heart Association, San Francisco Chapter. Public Awareness Study 64147. Princeton, NJ: Opinion Research Corporation; 1989.
9. Rosen DM, Pulk RR. Delay in presentation of stroke patients: how long and why? Study design and interim results. Proceedings of the International Conference on Strokes, Geneva, Switzerland; 1991:77.
10. Ebrahim S. Clinical Epidemiology of Stroke. London: Oxford University Press; 1990:85.
11. Alberts MJ, Perry A, Dawson DV, Bertels C. Effects of public and professional education on the delay in presentation and referral of stroke patients. Stroke. 1992;23:352-356.
12. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
13. Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Trial (ECASS). JAMA. 1995;274:1017-1025.
14. American Heart Association. Heart and Stroke Facts. Dallas, TX: American Heart Association; 1994.
15. Lateef F, Anantharaman V. Brain attack: multifaceted potential for action. Singapore Med J. 1998;39:306-310.
16. Kothari R, Jauch E, Broderick J, et al. Acute stroke: delays to presentation and emergency department evaluation. Ann Emerg Med. 1999;33:3-8.
17. Wester P., et al. Factors associated with the time of presentation of acute stroke patients in an Israeli community hospital. Stroke. 1999;30:40-48.
18. Menon, SC. Critical factors determining access to acute stroke care. Neurology. 1998;51:427-432.
19. Kaplan, HI, Saddock, BJ. Comprehensive Textbook of Psychiatry. Baltimore, MD: Williams & Wilkins; 1995:451.
20. American Heart Association. Stroke. 1998;29:.